Association of the End-Stage Renal Disease Treatment Choices Payment Model With Home Dialysis Use at Kidney Failure Onset From 2016 to 2022
- PMID: 36848086
- PMCID: PMC9972188
- DOI: 10.1001/jamanetworkopen.2023.0806
Association of the End-Stage Renal Disease Treatment Choices Payment Model With Home Dialysis Use at Kidney Failure Onset From 2016 to 2022
Abstract
Importance: The Centers for Medicare & Medicaid Services designed a mandatory payment model to incentivize home dialysis use: the End-Stage Renal Disease Treatment Choices (ETC). Outpatient dialysis facilities and health care professionals providing nephrology services were randomly assigned to ETC participation at the hospital referral region level.
Objective: To assess the association between ETC and home dialysis use in the incident dialysis population in its first 18 months of implementation.
Design, setting, and participants: A cohort study with controlled, interrupted time series analysis of the US End-Stage Renal Disease Quality Reporting System database was conducted, using generalized estimating equations. All adults initiating home-based dialysis in the US between January 1, 2016, and June 30, 2022, without a prior kidney transplant were included in the analysis.
Exposures: Prior to vs after ETC onset in January 1, 2021, and random assignment to ETC participation of facilities and health care professionals involved in patient care.
Main outcomes and measures: Percentage of patients started on incident home dialysis and yearly change in percentage initiating home dialysis.
Results: A total of 817 177 adults initiated home dialysis during the study period, of whom 750 314 were included in the study cohort. The cohort included 41.4% women; 26.2% of the patients were Black, 17.4% were Hispanic, and 49.1% were White. Approximately half (49.6%) of the patients were aged at least 65 years. A total of 31.2% received care from health care professionals assigned to ETC participation, and 33.6% had Medicare fee-for-service coverage. Overall, home dialysis use increased from 10.0% in January 2016 to 17.4% in June 2022. Home dialysis use increased more in ETC markets than in non-ETC markets after January 2021 (by 1.07%; 95% CI, 0.16%-1.97%). The rate of increase in home dialysis use in the entire cohort nearly doubled after January 2021 to 1.66% per year (95% CI, 1.14%-2.19%) compared with before 2021, when the rate was 0.86% per year (95% CI, 0.75%-0.97%), but the difference in rate of increase in home dialysis use was not significant between ETC and non-ETC markets.
Conclusions and relevance: This study noted that, although the overall rate of dialysis use at home was greater after ETC implementation, the increase occurred more among patients in ETC markets than among those in non-ETC markets. These findings suggest that federal policy and financial incentives affected care for the entire incident dialysis population in the US.
Conflict of interest statement
Figures


Similar articles
-
Financial Incentives to Facilities and Clinicians Treating Patients With End-stage Kidney Disease and Use of Home Dialysis: A Randomized Clinical Trial.JAMA Health Forum. 2022 Oct 7;3(10):e223503. doi: 10.1001/jamahealthforum.2022.3503. JAMA Health Forum. 2022. PMID: 36206005 Free PMC article. Clinical Trial.
-
Pay-for-Performance Incentives for Home Dialysis Use and Kidney Transplant.JAMA Health Forum. 2024 Jun 30;5(6.9):e242055. doi: 10.1001/jamahealthforum.2024.2055. JAMA Health Forum. 2024. PMID: 38944762 Free PMC article.
-
Medicaid Expansion and Medicare-Financed Hospitalizations Among Adult Patients With Incident Kidney Failure.JAMA Health Forum. 2022 Nov 4;3(11):e223878. doi: 10.1001/jamahealthforum.2022.3878. JAMA Health Forum. 2022. PMID: 36331442 Free PMC article.
-
Centers for Medicare & Medicaid Services' Models to Improve Late-stage Chronic Kidney Disease and End-stage Renal Disease Care: Leveraging Nephrology Payment Policy to Achieve Value.Adv Chronic Kidney Dis. 2022 Jan;29(1):24-29. doi: 10.1053/j.ackd.2021.12.001. Adv Chronic Kidney Dis. 2022. PMID: 35690399 Review.
-
Implications of the End-Stage Renal Disease Treatment Choices Model among U.S. Dialysis Providers.Nephrol Nurs J. 2021 Jan-Feb;48(1):11-17. Nephrol Nurs J. 2021. PMID: 33683840 Review.
Cited by
-
Prescribing Peritoneal Dialysis in the United States.Clin J Am Soc Nephrol. 2024 Jun 1;19(6):688-690. doi: 10.2215/CJN.0000000000000481. Epub 2024 May 17. Clin J Am Soc Nephrol. 2024. PMID: 38758605 Free PMC article. No abstract available.
-
An Early Assessment of the ESKD Treatment Choices Model on Kidney Transplant Waitlisting.Clin J Am Soc Nephrol. 2025 Jan 1;20(1):9-11. doi: 10.2215/CJN.0000000629. Epub 2024 Dec 12. Clin J Am Soc Nephrol. 2025. PMID: 39666383 No abstract available.
-
Early Effects of the ESRD Treatment Choices Model on Kidney Transplant Waitlist Additions.Clin J Am Soc Nephrol. 2025 Jan 1;20(1):124-135. doi: 10.2215/CJN.0000000000000571. Epub 2024 Oct 16. Clin J Am Soc Nephrol. 2025. PMID: 39475825
-
In-Center Hemodialysis Experiences Among Latinx Adults: A Qualitative Study.Kidney Med. 2024 Sep 12;6(11):100902. doi: 10.1016/j.xkme.2024.100902. eCollection 2024 Nov. Kidney Med. 2024. PMID: 39435308 Free PMC article.
-
The way home: a scoping review of public health interventions to increase the utilization of home dialysis in chronic kidney disease patients.BMC Nephrol. 2025 Apr 1;26(1):169. doi: 10.1186/s12882-025-04072-9. BMC Nephrol. 2025. PMID: 40170151 Free PMC article.
References
-
- United States Renal Data System. 2022 Annual data report. Published 2022. Accessed October 29, 2022. https://adr.usrds.org/2022/
-
- Centers for Medicare and Medicaid Services . ESRD Treatment Choices (ETC) model. 2022. Updated June 3, 2022. Accessed June 16, 2022 https://innovation.cms.gov/innovation-models/esrd-treatment-choices-model
-
- Desai TP. Advancing American Kidney Health: the ultimate randomized controlled trial? WebMD. Medscape Nephrology website. July 19, 2019. Accessed May 31, 2022. https://www.medscape.com/viewarticle/915660?ecd=ppc_google_rlsa-traf_msc...
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical